These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 9541587)
1. Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants. Akdis CA; Blesken T; Wymann D; Akdis M; Blaser K Eur J Immunol; 1998 Mar; 28(3):914-25. PubMed ID: 9541587 [TBL] [Abstract][Full Text] [Related]
2. Enzymatic activity of soluble phospholipase A2 does not affect the specific IgE, IgG4 and cytokine responses in bee sting allergy. Wymann D; Akdis CA; Blesken T; Akdis M; Crameri R; Blaser K Clin Exp Allergy; 1998 Jul; 28(7):839-49. PubMed ID: 9720818 [TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids inhibit human antigen-specific and enhance total IgE and IgG4 production due to differential effects on T and B cells in vitro. Akdis CA; Blesken T; Akdis M; Alkan SS; Heusser CH; Blaser K Eur J Immunol; 1997 Sep; 27(9):2351-7. PubMed ID: 9341780 [TBL] [Abstract][Full Text] [Related]
4. Allergen dose dependent cytokine production regulates specific IgE and IgG antibody production. Blaser K Adv Exp Med Biol; 1996; 409():295-303. PubMed ID: 9095257 [TBL] [Abstract][Full Text] [Related]
5. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. Akdis CA; Akdis M; Blesken T; Wymann D; Alkan SS; Müller U; Blaser K J Clin Invest; 1996 Oct; 98(7):1676-83. PubMed ID: 8833918 [TBL] [Abstract][Full Text] [Related]
6. Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells. Akdis CA; Blesken T; Akdis M; Alkan SS; Wüthrich B; Heusser CH; Blaser K J Allergy Clin Immunol; 1997 Mar; 99(3):345-53. PubMed ID: 9058690 [TBL] [Abstract][Full Text] [Related]
7. Regulation of IgE and IgG4 responses by allergen specific T-cell clones to bee venom phospholipase A2 in vitro. Carballido JM; Carballido-Perrig N; Oberli-Schrämmli A; Heusser CH; Blaser K J Allergy Clin Immunol; 1994 Apr; 93(4):758-67. PubMed ID: 8163785 [TBL] [Abstract][Full Text] [Related]
8. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. Müller U; Akdis CA; Fricker M; Akdis M; Blesken T; Bettens F; Blaser K J Allergy Clin Immunol; 1998 Jun; 101(6 Pt 1):747-54. PubMed ID: 9648701 [TBL] [Abstract][Full Text] [Related]
9. Role of interleukin 10 in specific immunotherapy. Akdis CA; Blesken T; Akdis M; Wüthrich B; Blaser K J Clin Invest; 1998 Jul; 102(1):98-106. PubMed ID: 9649562 [TBL] [Abstract][Full Text] [Related]
10. Determinants and mechanisms of human immune responses to bee venom phospholipase A2. Blaser K; Carballido J; Faith A; Crameri R; Akdis C Int Arch Allergy Immunol; 1998 Sep; 117(1):1-10. PubMed ID: 9751842 [TBL] [Abstract][Full Text] [Related]
11. Regulation of human T helper cell differentiation by antigen-presenting cells: the bee venom phospholipase A2 model. Carballido JM; Carballido-Perrig N; Schwärzler C; Lametschwandtner G Chem Immunol Allergy; 2006; 91():147-58. PubMed ID: 16354956 [TBL] [Abstract][Full Text] [Related]
12. Antigen-independent suppression of the allergic immune response to bee venom phospholipase A(2) by DNA vaccination in CBA/J mice. Jilek S; Barbey C; Spertini F; Corthésy B J Immunol; 2001 Mar; 166(5):3612-21. PubMed ID: 11207323 [TBL] [Abstract][Full Text] [Related]
13. Bee venom phospholipase A2-specific T cell clones from human allergic and non-allergic individuals: cytokine patterns change in response to the antigen concentration. Carballido JM; Carballido-Perrig N; Terres G; Heusser CH; Blaser K Eur J Immunol; 1992 Jun; 22(6):1357-63. PubMed ID: 1601030 [TBL] [Abstract][Full Text] [Related]
14. High-dose bee venom exposure induces similar tolerogenic B-cell responses in allergic patients and healthy beekeepers. Boonpiyathad T; Meyer N; Moniuszko M; Sokolowska M; Eljaszewicz A; Wirz OF; Tomasiak-Lozowska MM; Bodzenta-Lukaszyk A; Ruxrungtham K; van de Veen W Allergy; 2017 Mar; 72(3):407-415. PubMed ID: 27341567 [TBL] [Abstract][Full Text] [Related]
15. Increased specificity of diagnostic tests with recombinant major bee venom allergen phospholipase A2. Müller U; Fricker M; Wymann D; Blaser K; Crameri R Clin Exp Allergy; 1997 Aug; 27(8):915-20. PubMed ID: 9291289 [TBL] [Abstract][Full Text] [Related]
16. Selective restimulation of antigen or allergen preactivated T cells using OKT3 F(ab)2 results in the secretion of TH-1 or TH-2-like cytokine patterns. Jutel M; Wyss-Coray T; Carballido JM; Blaser K; Müller UR; Pichler WJ Clin Exp Allergy; 1995 Nov; 25(11):1108-17. PubMed ID: 8581844 [TBL] [Abstract][Full Text] [Related]
17. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Bellinghausen I; Metz G; Enk AH; Christmann S; Knop J; Saloga J Eur J Immunol; 1997 May; 27(5):1131-9. PubMed ID: 9174602 [TBL] [Abstract][Full Text] [Related]
18. An altered peptide ligand specifically inhibits Th2 cytokine synthesis by abrogating TCR signaling. Faith A; Akdis CA; Akdis M; Joss A; Wymann D; Blaser K J Immunol; 1999 Feb; 162(3):1836-42. PubMed ID: 9973449 [TBL] [Abstract][Full Text] [Related]
19. Human atopen-specific types 1 and 2 T helper cell clones. Wierenga EA; Snoek M; Jansen HM; Bos JD; van Lier RA; Kapsenberg ML J Immunol; 1991 Nov; 147(9):2942-9. PubMed ID: 1680923 [TBL] [Abstract][Full Text] [Related]
20. Natural and recombinant enzymatically active or inactive bee venom phospholipase A2 has the same potency to release histamine from basophils in patients with Hymenoptera allergy. Förster E; Dudler T; Gmachl M; Aberer W; Urbanek R; Suter M J Allergy Clin Immunol; 1995 Jun; 95(6):1229-35. PubMed ID: 7541059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]